250 related articles for article (PubMed ID: 18554745)
1. Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
Zeuzem S
J Hepatol; 2008 Aug; 49(2):157-9. PubMed ID: 18554745
[No Abstract] [Full Text] [Related]
2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C.
Rakov NE
N Engl J Med; 2003 Jan; 348(3):259-60; author reply 259-60. PubMed ID: 12529472
[No Abstract] [Full Text] [Related]
3. Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!".
Baiocchi L; Lenci I; Carbone M; Angelico M
Hepatology; 2009 Nov; 50(5):1676-7. PubMed ID: 19876945
[No Abstract] [Full Text] [Related]
4. Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.
Forestier N; Reesink HW; Weegink CJ; McNair L; Kieffer TL; Chu HM; Purdy S; Jansen PL; Zeuzem S
Hepatology; 2007 Sep; 46(3):640-8. PubMed ID: 17879366
[TBL] [Abstract][Full Text] [Related]
5. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
[TBL] [Abstract][Full Text] [Related]
6. Peginterferon and ribavirin for hepatitis C.
Abramowicz M
N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
[No Abstract] [Full Text] [Related]
7. Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.
Lawitz E; Rodriguez-Torres M; Muir AJ; Kieffer TL; McNair L; Khunvichai A; McHutchison JG
J Hepatol; 2008 Aug; 49(2):163-9. PubMed ID: 18486984
[TBL] [Abstract][Full Text] [Related]
8. ADVANCE study begins enrollment.
AIDS Patient Care STDS; 2008 Apr; 22(4):345. PubMed ID: 18422463
[No Abstract] [Full Text] [Related]
9. A step forward in therapy for hepatitis C.
Hoofnagle JH
N Engl J Med; 2009 Apr; 360(18):1899-901. PubMed ID: 19403908
[No Abstract] [Full Text] [Related]
10. Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
Rustgi VK; Esposito S; Hamzeh FM; Shiffman ML
Aliment Pharmacol Ther; 2008 Mar; 27(5):433-40. PubMed ID: 18081737
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
[TBL] [Abstract][Full Text] [Related]
12. Peginterferon and ribavirin for hepatitis C.
Duggan AE; Duggan JM
N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17377169
[No Abstract] [Full Text] [Related]
13. Chronic hepatitis C successfully treated with telaprevir, pegylated interferon and ribavirin in severe aplastic anemia.
Balkan II; Bozcan S; Yemisen M; Kutlubay Z; Ozaras R
Ann Hepatol; 2014; 13(6):843-4. PubMed ID: 25332274
[No Abstract] [Full Text] [Related]
14. Successful treatment after short course of telaprevir-based therapy in chronic hepatitis C infected patient.
Dutilh JC; Arends JE
Neth J Med; 2013 Sep; 71(7):391-2. PubMed ID: 24038569
[No Abstract] [Full Text] [Related]
15. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
Taylor LE; Rich JD; Tashima KT
N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15564553
[No Abstract] [Full Text] [Related]
16. [An open-label pilot study evaluating the efficacy and safety of peginterferon alfa-2a combined with ribavirin in children with chronic hepatitis C].
Zhang HF; Yang XJ; Zhu SS; Dong Y; Chen DW; Jia WZ; Xu ZQ; Mao YL; Tang HM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):185-7. PubMed ID: 16027794
[TBL] [Abstract][Full Text] [Related]
17. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
Gholam PM
N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15570682
[No Abstract] [Full Text] [Related]
18. Peginterferon and ribavirin for chronic hepatitis C.
Hoofnagle JH; Seeff LB
N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
[No Abstract] [Full Text] [Related]
19. Treatment of chronic hepatitis C infection with peginterferons plus ribavirin.
Fried MW; Hadziyannis SJ
Semin Liver Dis; 2004; 24 Suppl 2():47-54. PubMed ID: 15346246
[TBL] [Abstract][Full Text] [Related]
20. [A case of chronic hepatitis C with pancreas divisum and acute pancreatitis during combination treatment with telaprevir/peginterferon/ribavirin].
Morio R; Imamura M; Fukuhara T; Kan H; Fujino H; Kawaoka T; Hiramatsu A; Aikata H; Sasaki T; Chayama K
Nihon Shokakibyo Gakkai Zasshi; 2014 Oct; 111(10):1997-2003. PubMed ID: 25283229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
